Institut Claudius Regaud
Clinical trials sponsored by Institut Claudius Regaud, explained in plain language.
-
New drug combo aims to stop prostate Cancer's return
Disease control OngoingThis study is testing whether adding a medication called darolutamide to standard prostate cancer surgery works better than surgery alone for men with high-risk or locally advanced prostate cancer. About 240 participants will be randomly assigned to receive either just surgery or…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Can a quick chat with your GP ease the shock of a cancer diagnosis?
Knowledge-focused OngoingThis study is testing whether it's practical to schedule a follow-up visit with a patient's regular family doctor soon after they are told they have cancer. It involves 171 adults with solid tumors in France. The main goal is to see how many patients actually attend this extra vi…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Mar 13, 2026 15:05 UTC